Cargando…
Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges
Early detection, right therapeutic intervention, and simultaneous effectiveness mapping are considered the critical factors in successful cancer therapy. Nevertheless, these factors experience the limitations of conventional cancer diagnostics and therapeutics delivery approaches. Along with providi...
Autores principales: | Alshehri, Sultan, Imam, Syed Sarim, Rizwanullah, Md., Akhter, Sohail, Mahdi, Wael, Kazi, Mohsin, Ahmad, Javed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823416/ https://www.ncbi.nlm.nih.gov/pubmed/33374391 http://dx.doi.org/10.3390/pharmaceutics13010024 |
Ejemplares similares
-
Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges
por: Bukhari, Sarah I., et al.
Publicado: (2021) -
Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges
por: Rizwanullah, Md., et al.
Publicado: (2021) -
Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments
por: Rahat, Iqra, et al.
Publicado: (2021) -
Nanotechnology-based inhalation treatments for lung cancer: state of the art
por: Ahmad, Javed, et al.
Publicado: (2015) -
Formulation of
Silymarin-β Cyclodextrin-TPGS
Inclusion Complex: Physicochemical Characterization, Molecular Docking,
and Cell Viability Assessment against Breast Cancer Cell Lines
por: Imam, Syed Sarim, et al.
Publicado: (2023)